Introducing more openness in commercial relationships

As the NHS and the ABPI introduce measures to improve transparency in drug development, Prescriber reports from the recent Guardian debate in London examining this thorny issue.

Source: Prescriber - June 22, 2016 Category: Primary Care Authors: Roberta Ellison Tags: News Feature Source Type: research